These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21329680)

  • 1. Human and rodent aldo-keto reductases from the AKR1B subfamily and their specificity with retinaldehyde.
    Ruiz FX; Moro A; Gallego O; Ardèvol A; Rovira C; Petrash JM; Parés X; Farrés J
    Chem Biol Interact; 2011 May; 191(1-3):199-205. PubMed ID: 21329680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering aldo-keto reductase 1B10 to mimic the distinct 1B15 topology and specificity towards inhibitors and substrates, including retinoids and steroids.
    Giménez-Dejoz J; Weber S; Fernández-Pardo Á; Möller G; Adamski J; Porté S; Parés X; Farrés J
    Chem Biol Interact; 2019 Jul; 307():186-194. PubMed ID: 31028727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldo-keto reductases from the AKR1B subfamily: retinoid specificity and control of cellular retinoic acid levels.
    Ruiz FX; Gallego O; Ardèvol A; Moro A; Domínguez M; Alvarez S; Alvarez R; de Lera AR; Rovira C; Fita I; Parés X; Farrés J
    Chem Biol Interact; 2009 Mar; 178(1-3):171-7. PubMed ID: 19014918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10.
    Gallego O; Ruiz FX; Ardèvol A; Domínguez M; Alvarez R; de Lera AR; Rovira C; Farrés J; Fita I; Parés X
    Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20764-9. PubMed ID: 18087047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of AKR1B16, a novel mouse aldo-keto reductase.
    Giménez-Dejoz J; Weber S; Barski OA; Möller G; Adamski J; Parés X; Porté S; Farrés J
    Chem Biol Interact; 2017 Oct; 276():182-193. PubMed ID: 28322781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate Specificity, Inhibitor Selectivity and Structure-Function Relationships of Aldo-Keto Reductase 1B15: A Novel Human Retinaldehyde Reductase.
    Giménez-Dejoz J; Kolář MH; Ruiz FX; Crespo I; Cousido-Siah A; Podjarny A; Barski OA; Fanfrlík J; Parés X; Farrés J; Porté S
    PLoS One; 2015; 10(7):e0134506. PubMed ID: 26222439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldo-keto reductases in retinoid metabolism: search for substrate specificity and inhibitor selectivity.
    Porté S; Xavier Ruiz F; Giménez J; Molist I; Alvarez S; Domínguez M; Alvarez R; de Lera AR; Parés X; Farrés J
    Chem Biol Interact; 2013 Feb; 202(1-3):186-94. PubMed ID: 23220004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selectivity determinants of inhibitor binding to the tumour marker human aldose reductase-like protein (AKR1B10) discovered from molecular docking and database screening.
    Zhao HT; Soda M; Endo S; Hara A; El-Kabbani O
    Eur J Med Chem; 2010 Sep; 45(9):4354-7. PubMed ID: 20538382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological role of aldo-keto reductases in retinoic Acid biosynthesis and signaling.
    Ruiz FX; Porté S; Parés X; Farrés J
    Front Pharmacol; 2012; 3():58. PubMed ID: 22529810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel polyfluorinated compound as a lead to inhibit the human enzymes aldose reductase and AKR1B10: structure determination of both ternary complexes and implications for drug design.
    Cousido-Siah A; Ruiz FX; Mitschler A; Porté S; de Lera ÁR; Martín MJ; Manzanaro S; de la Fuente JA; Terwesten F; Betz M; Klebe G; Farrés J; Parés X; Podjarny A
    Acta Crystallogr D Biol Crystallogr; 2014 Mar; 70(Pt 3):889-903. PubMed ID: 24598757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10.
    Joshi A; Rajput S; Wang C; Ma J; Cao D
    Biol Chem; 2010 Dec; 391(12):1371-8. PubMed ID: 21087085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative functional analysis of human medium-chain dehydrogenases, short-chain dehydrogenases/reductases and aldo-keto reductases with retinoids.
    Gallego O; Belyaeva OV; Porté S; Ruiz FX; Stetsenko AV; Shabrova EV; Kostereva NV; Farrés J; Parés X; Kedishvili NY
    Biochem J; 2006 Oct; 399(1):101-9. PubMed ID: 16787387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
    O'connor T; Ireland LS; Harrison DJ; Hayes JD
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes.
    Spite M; Baba SP; Ahmed Y; Barski OA; Nijhawan K; Petrash JM; Bhatnagar A; Srivastava S
    Biochem J; 2007 Jul; 405(1):95-105. PubMed ID: 17381426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of human aldehyde reductase: characterization of the active site pocket.
    Barski OA; Gabbay KH; Grimshaw CE; Bohren KM
    Biochemistry; 1995 Sep; 34(35):11264-75. PubMed ID: 7669785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of an aldo-keto reductase from Marivirga tractuosa that converts retinal to retinol.
    Hong SH; Nam HK; Kim KR; Kim SW; Oh DK
    J Biotechnol; 2014 Jan; 169():23-33. PubMed ID: 24269309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification, cloning and regulation of cDNA encoding aldo-keto reductase 1B7 in the adrenal gland of two Saharan rodents Meriones libycus (Libyan jird) and Gerbillus gerbillus (gerbil).
    Mataoui-Mazari H; Amirat Z; Khammar F; Martinez A
    Gen Comp Endocrinol; 2011 Dec; 174(3):292-300. PubMed ID: 21963864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decoding selectivity: computational insights into AKR1B1 and AKR1B10 inhibition.
    Liu M; Qin X; Li J; Jiang Y; Jiang J; Guo J; Xu H; Wang Y; Bi H; Wang Z
    Phys Chem Chem Phys; 2024 Mar; 26(12):9295-9308. PubMed ID: 38469695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin F2alpha synthase activities of aldo-keto reductase 1B1, 1B3 and 1B7.
    Kabututu Z; Manin M; Pointud JC; Maruyama T; Nagata N; Lambert S; Lefrançois-Martinez AM; Martinez A; Urade Y
    J Biochem; 2009 Feb; 145(2):161-8. PubMed ID: 19010934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
    Ruiz FX; Cousido-Siah A; Mitschler A; Farrés J; Parés X; Podjarny A
    Chem Biol Interact; 2013 Feb; 202(1-3):178-85. PubMed ID: 23295227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.